...
首页> 外文期刊>The Journal of Bone and Joint Surgery. American Volume >Extendable Endoprostheses in Skeletally Immature Patients A Study of 124 Children Surviving More Than 10 Years After Resection of Bone Sarcomas
【24h】

Extendable Endoprostheses in Skeletally Immature Patients A Study of 124 Children Surviving More Than 10 Years After Resection of Bone Sarcomas

机译:骨骼未成熟患者的可扩展内置患者对124名儿童在切除骨骼肉瘤切除后超过10年的儿童存活

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: Extendable endoprostheses are used to reconstruct segmental defects following resection of bone sarcomas in skeletally immature patients. However, there remains a paucity of studies with regard to long-term outcomes. Methods: We retrospectively reviewed 124 skeletally immature children who underwent an extendable endoprosthetic replacement and survived more than 10 years after the surgical procedures. Anatomical sites included the distal part of the femur (n = 66), the proximal part of the femur (n = 13), the proximal part of the tibia (n = 29), and the proximal part of the humerus (n = 16). Complications and implant survival were classified according to the modified Henderson criteria. Results: The mean follow-up was 24 years (range, 10 to 36 years). The mean age at the time of the extendable endoprosthetic replacement was 9 years (range, 2 to 16 years). All patients had reached skeletal maturity at the last follow-up. The 10-year endoprosthetic failure-free survival rate was 28%. A total of 243 complications occurred in 90% of patients; these complications were most frequently related to soft-tissue problems (27% of complications). The incidence of and cumulative survival with respect to each failure mode varied between anatomical sites. Soft-tissue failures occurred most frequently in the proximal part of the femur (77%; p = 0.003), and the distal part of the femur was the most frequent site of aseptic loosening (52%; p = 0.014) and structural failure (55%; p = 0.001). Excluding lengthening procedures, 105 patients (85%) underwent an additional surgical procedure, with a mean of 2.7 surgical procedures per patient (range, 0 to 7 surgical procedures per patient). The mean limb-length discrepancy at the final follow-up was 1 cm (range, 0 to 9 cm). Limb salvage was achieved in 113 patients (91%). The mean Musculoskeletal Tumor Society functional score (the percentage of a total score of 30 points) was 82% (range, 40% to 100%) in 115 patients with available data at the last follow-up. Conclusions: Extendable endoprostheses are associated with a high complication rate and a need for additional surgical procedures over time. Despite this, successful limb salvage with reasonable function and small limb-length discrepancy is achievable in the long term. Our study provides benchmark data for individual anatomical sites for further improvements of outcomes.
机译:背景:可延伸内保护剂用于在骨骼未成熟患者切除骨骼肉瘤后重建节段缺陷。但是,在长期成果方面仍有缺乏研究。方法:我们回顾性地审查了124名骨骼未成熟的儿童,在手术手术程序后超过10年内幸存下来。解剖部位包括股骨(n = 66)的远端部分,股骨(n = 13)的近端部分,胫骨的近侧部分(n = 29),以及肱骨的近侧部分(n = 16 )。根据改性的亨德森标准对并发症和植入物存活。结果:平均随访24岁(范围,10至36岁)。可伸展内保护型更换时间的平均年龄为9年(范围,2至16岁)。所有患者在最后一次随访时达到了骨骼成熟。 10年内的内置衰竭生存率为28%。 90%的患者共发生243个并发症;这些并发症最常与软组织问题(27%的并发症)有关。关于解剖部位之间的每种故障模式的发生率和累积生存率变化。软组织故障最常发生在股骨的近端部分(77%; p = 0.003),股骨的远端部分是无菌松动的最常见的部位(52%; p = 0.014)和结构失败( 55%; p = 0.001)。不包括延长程序,105名患者(85%)进行了额外的外科手术,平均每位患者22.7手术程序(范围,每位患者的0至7种外科手术)。最终后续的平均肢体长度差异为1厘米(范围,0至9cm)。 113名患者(91%)达到肢体救生。平均肌肉骨骼肿瘤社会功能得分(总分30分的百分比)为上次随访时的115名可用数据的115名患者中为82%(范围,40%至100%)。结论:可延伸内保护剂与高并发症率相关,并且随着时间的推移需要额外的外科手术。尽管如此,长期可实现具有合理功能和小肢体长度差异的成功肢体救助。我们的研究为各个解剖站点提供了基准数据,以进一步改进结果。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号